Treat and extend compared to pro re nata regimen in neovascular age-related macular degeneration
Author(s) -
Rodolfo Garretón
Publication year - 2020
Publication title -
medwave
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.178
H-Index - 7
ISSN - 0717-6384
DOI - 10.5867/medwave.2020.08.8023
Subject(s) - pro re nata , macular degeneration , medicine , regimen , peer review , optometry , ophthalmology , family medicine , gerontology , ranibizumab , bevacizumab , chemotherapy , political science , law
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom